The effect of long-term cigarette smoking on ,B-adrenoceptor density and catecholamine response was studied in 10 monozygotic male twin-pairs discordant for smoking, with an average discordance time for smoking of 23 years (range, 12-35 29.2 6.5 pmol/106 cells, p<0.05). When subjected to submaximal exercise, the smokers had a lower level of cyclic adenosine monophosphate in plasma (25.9 ± 1.2 vs. 28.6 ± 1.0, p<0.05) and a net decrease was seen in plasma free fatty acids in the smokers compared with a net increase in the nonsmokers ( -15% vs. + 19%, p<0.01). The total plasma catecholamine level was, in the basal state, significantly higher in smokers compared with nonsmokers (74.8%, p<0.05). The intrapair difference in plasma norepinephrine predicted well the intrapair difference in fl-receptor density (r = -0.84, p<0.001). We conclude that the autonomic neurohumoral response evoked by cigarette smoking results in downregulation of P-adrenergic receptors in long-term smokers. (Circulation 1988;78:1234-1240 C igarette smoking is considered to be a major risk factor of atherosclerotic disease and its acute complications (e.g., sudden death, stroke, and acute myocardial infarction).1-3 Smoking appears to induce increased sympathetic discharge and leads to an increase in plasma levels of both the adrenomedullary hormone epinephrine and the sympathetic neurotransmitter norepinephrine.4 The increments in pulse rate, blood pressure, and lipolysis are probably due to this increased sympathetic discharge during smoking.45 However, the long-term effects of smoking on the autonomic nervous system have not been as evident. Surprisingly, epidemiological studies show smokers to have a lower rather than a higher blood pressure com-
29.2 6.5 pmol/106 cells, p<0.05). When subjected to submaximal exercise, the smokers had a lower level of cyclic adenosine monophosphate in plasma (25.9 ± 1.2 vs. 28.6 ± 1.0, p<0.05) and a net decrease was seen in plasma free fatty acids in the smokers compared with a net increase in the nonsmokers ( -15% vs. + 19%, p<0.01). The total plasma catecholamine level was, in the basal state, significantly higher in smokers compared with nonsmokers (74.8%, p<0.05). The intrapair difference in plasma norepinephrine predicted well the intrapair difference in fl-receptor density (r = -0.84, p<0.001). We conclude that the autonomic neurohumoral response evoked by cigarette smoking results in downregulation of P-adrenergic receptors in long-term smokers. (Circulation 1988; 78:1234 -1240 C igarette smoking is considered to be a major risk factor of atherosclerotic disease and its acute complications (e.g., sudden death, stroke, and acute myocardial infarction). [1] [2] [3] Smoking appears to induce increased sympathetic discharge and leads to an increase in plasma levels of both the adrenomedullary hormone epinephrine and the sympathetic neurotransmitter norepinephrine. 4 The increments in pulse rate, blood pressure, and lipolysis are probably due to this increased sympathetic discharge during smoking.45 However, the long-term effects of smoking on the autonomic nervous system have not been as evident. Surprisingly, epidemiological studies show smokers to have a lower rather than a higher blood pressure com-pared with nonsmokers.6 It has also recently been shown that smoking may be associated with an increased formation of prostacyclin, the antiaggregatory and vasodilatory eicosanoid, secreted by the endothelium.7 These observations suggest the existence of a complicated set of compensatory mechanisms in response to the harmful short-term effects of smoking. The present study was undertaken to elucidate whether the continuous increments in catecholamines in nerve endings and plasma are reflected in changes in the density and sensitivity of ,B-adrenergic receptors.
Subjects and Methods Characteristics of Study Population
Ten monozygotic male twin-pairs who were discordant with respect to cigarette smoking were enrolled from the Finnish Twin Cohort Study, a nationwide twin panel.8 Their mean age was 40 years (range, 31-53 years). The smoking cotwin had a history of at least 10 years of uninterrupted cigarette use, whereas the nonsmoking cotwin was accepted for the study if he had never smoked least for 2 hours before the tests and had ingested no coffee on the morning of the tests. They had also abstained from alcohol for the preceding 48 hours. Subjects reclined in a supine position for 30 minutes before the blood samples were taken for measurement of baseline values. After the initial blood sampling, an exercise test was carried out with a bicycle ergometer.
The workload was increased in steps of 50 W to reach a heart rate corresponding to 85% of the ageadjusted maximum.'1 A second blood sample for determination of exercise values of plasma cyclic adenosine monophosphate, catecholamines, and free fatty acids was drawn immediately after reaching the peak heart rate.
Preparation of Lymphocytes
Lymphocytes were isolated by gradient separation with the method of Boyum. 12 Sixty milliliters of blood was drawn into Venoject tubes containing ethylenediaminetetraacetic acid (EDTA) (0.38 M). The lymphocytes were separated with Ficoll-Paque (Pharmacia, Uppsala, Sweden). Binding studies were carried out on intact human lymphocytes with a modification of the method described by Halper et al. 13 One milliliter of the cell suspension was used for the studies of ,-receptor density.
ing studies. The reaction mixture was incubated for 60 minutes at 370 C. Bound and free ligand were then separated by adding 10 ml of a mixture containing 0.9% NaCI 10 mM Tris-HCI and 12.5 mM MgCI at 37°C followed by rapid filtration through Whatman GF/C filters (Whatman, Clifton, New Jersey). Each filter was then washed with an additional 10 ml buffer, and the retained radioactivity was determined in a 1272 Clinigamma gamma counter (LKB-Wallac, Turku, Finland). Nonspecific binding was defined as the binding not competed for by 0.1 mM isoproterenol. /3-Receptor density (Bmax) and affinity (Kd) For plasma catecholamine determinations, 9 ml blood was taken into Venoject tubes containing 1 ml of a solution containing 90 mg ethyleneglycol-bis-(,3-aminoethyl ether)-N,N,N' ,N'-tetraacetic acid (EGTA) and 60 mg reduced glutathione. The blood was centrifugated, and the supernatant was stored at -80°C. Plasma epinephrine and norepinephrine were determined with high-performance liquid chromatography (HPLC) with electrochemical detection and dihydroxybenzylamine as internal standard as described by Goldstein et al. 15 The HPLC apparatus consisted of a sample injector (Model U6K, Waters, West Lafayette, Indiana), a solvent delivery system (Model 6000A, Waters), Microbondapak C'8-column (Waters), and an amperometric detector with glassy carbon electrode (Model LC-4, Bioanalytical Systems, West Lafayette, Indiana).
Five milliliters of EDTA plasma was used for the determination of free fatty acids. Lipids were extracted from 0.50-ml aliquots of plasma and determined as described previously.'6 Free fatty acids were isolated by thin layer chromatography, converted to their methyl esters, and analyzed with gas chromatography (Model 5880 A, HewlettPackard, Avondale, Pennsylvania).
Statistical Analyses
Student's t test for paired data was used in the statistical analyses. Linear regression analysis by the least-squares method was performed to analyze The density of /-receptors in the lymphocytes of the cigarette-smoking cotwins was reduced in nine of the 10 pairs, being 40% lower in the smoking cotwins compared with the nonsmokers (p<0.05, Table 3 and Figure 1 ). The apparent Kd values did not differ between the two groups ( Table 3 ). The basal level of cyclic AMP in the lymphocytes was the same in nonsmokers and smokers (Table 3) . However, stimulation with 10 JLM isoproterenol resulted in a significantly lower level of cyclic AMP in the lymphocytes of smokers compared with nonsmokers (45%, p <0.05, Table 3 ). The absolute increase (stimulated minus basal) in cyclic AMP was 44% less (p <0.05, Table 3 ) in smokers compared with nonsmokers, and the relative increase (stimulated/basal) was 56% less (p <0.05, Table 3) .
The mean plasma level of epinephrine was more in smokers at rest (49%, Table 4 ), but the difference was not significant. The plasma level of norepinephrine was also more in smokers than in nonsmokers at rest (66%, Table 4 ), but again this difference was not significant. However, the total catecholamine level, expressed as epinephrine plus norepinephrine, was significantly elevated in smokers compared with nonsmokers at rest in the basal state (75%, p<O.05, Table 4 ). At peak heart rate (85% of age-adjusted maximum), the plasma level of norepinephrine increased further in smokers and nonsmokers, whereas the level of epinephrine increased during exercise only in the nonsmokers. However, the total catecholamine level, expressed as epinephrine plus norepinephrine, was still slightly more at peak heart rate in smokers than in nonsmokers (17%, NS, mal exercise resulted in a significantly higher level of cAMP in plasma in the nonsmokers compared with the smokers (9%, p<0.05, Table 4 ). Exercise resulted in a increase in plasma free fatty acids in eight nonsmokers (mean increase, 19%), whereas there was a decrease in plasma free fatty acids during exercise in nine smokers (mean decrease, 15%; Figure 3) p<0.001) was found between the intrapair difference in Bmax and the intrapair difference in norepinephrine ( Figure 2 ). The correlation between the intrapair difference in Bmax and the intrapair difference in epinephrine was nonsignificant (r= -0.28, Figure 2 ). The plasma level of cyclic AMP in the basal state was slightly lower in the smokers than in the nonsmokers (6%, NS, Table 4 ). However, submaxi-
Discussion
The present study provides two sets of findings that suggest downregulation of f3-adrenergic receptors in long-term cigarette smokers. Ligand binding to the fl-receptors is decreased, and stimulation of lymphocytes by isoproterenol results in decreased formation of cyclic AMP. In addition to this direct evidence, the significantly lower plasma level of cyclic AMP and the decrease of the level of free fatty acids in smokers during exercise are also indications of an impaired catecholamine response, especially, because there was a tendency toward higher (17%) catecholamine levels in the plasma of smokers compared with nonsmokers at peak heart rate during exercise. These findings seem to imply that the fl-receptors of other cell systems than the lymphocytes (e.g., the f-receptors of the adipose tissue) were also downregulated in smokers.
The level of free fatty acids in plasma during exercise reflects both the rate of lipolysis and the uptake rate by the working muscles. 17 Earlier studies indicate a decreased,'1819 an unchanged,20 and an increased21,22 plasma level of free fatty acids during exercise, depending on the load and the duration of exercise applied. The most common finding, in association with prolonged exercise, is an increase in the plasma level of free fatty acids.23 However, the consumption of fatty acids may, during vigorous short-term exercise, be more than the amount provided by lipolysis. This is reflected as a decrease in the plasma level of free fatty acids. The exercise applied in the present study was short-term (mean, 10 minutes) during which no steady state was reached. This led in the nonsmokers to a small nonsignificant increase in the plasma level of free fatty acids, whereas there was in the smokers a it.35 Cigarette smoke-or nicotine-induced platelet thrombus formation in the stenosed dog coronary artery can be antagonized with the a-adrenergic blocker phentolamine.36 These observations indicate that cigarette smoking may induce an increase in a-adrenergic tone, with considerable impact on cardiovascular regulation. The present results imply that even if a-receptor function per se is unaltered in cigarette smokers, the downregulation of ,Breceptors may result in a relative increase in aadrenergic tone at any given catecholamine concentration. This could explain the increased vasoconstrictive tendency found in the coronary vasculature of cigarette smokers.
In summary, the present study shows that longterm smoking induces downregulation of /3-adrenergic receptors in genetically matched pairs.
This finding may explain why p-blockers tend, in some studies, to be less effective in the treatment of hypertension or angina pectoris in smokers compared with nonsmokers. 
